These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1092756)

  • 21. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.
    Olive C; Ho MF; Dyer J; Lincoln D; Barozzi N; Toth I; Good MF
    J Infect Dis; 2006 Jun; 193(12):1666-76. PubMed ID: 16703510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The significance of antipolysaccharide C antibodies from Streptococcus group A. Their importance in the diagnosis of streptococcal infections].
    Soffritti E; Bellodi L; Bernardoni R; Pelizzola D; Sandri MR
    Boll Ist Sieroter Milan; 1986; 65(2):138-42. PubMed ID: 3527228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [OF- and anti-OF test systems in microbiological and epidemiologic practice].
    Beliakova IV; Totolian AA
    Vestn Akad Med Nauk SSSR; 1989; (11):54-9. PubMed ID: 2483011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological considerations following long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1992-2003.
    Vlaminckx BJ; van Pelt W; Schellekens JF
    Clin Microbiol Infect; 2005 Jul; 11(7):564-8. PubMed ID: 15966975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The demonstration of M-protein-antibodies to Streptococcus pyogenes. A comparison of latex agglutination, ouchterlony test, long-chain reaction and indirect bactericidal test].
    Köhler W; Kühnemund O
    Zentralbl Bakteriol Orig A; 1973 Mar; 223(2):286-97. PubMed ID: 4123224
    [No Abstract]   [Full Text] [Related]  

  • 26. A bacteriological and/or immunological study of anaerobic streptococcal infection in chronic tonsillitis, paratonsillitis and periodontitis patients.
    Povolotskii YL; Fal NI; Smol'nikova LI; Timen GE; Marchenko NN
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(3):308-14. PubMed ID: 7142691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Simultaneous determination of antistreptolysins O and antistreptodornases B in streptococcal cutaneous infections].
    Scheftel JM; Laplanche G; Freydière MH; Grosshans E
    Ann Dermatol Venereol; 1982; 109(12):1031-6. PubMed ID: 7171200
    [No Abstract]   [Full Text] [Related]  

  • 28. High diversity of group A Streptococcal emm types in an Indian community: the need to tailor multivalent vaccines.
    Dey N; McMillan DJ; Yarwood PJ; Joshi RM; Kumar R; Good MF; Sriprakash KS; Vohra H
    Clin Infect Dis; 2005 Jan; 40(1):46-51. PubMed ID: 15614691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological observations on Streptococcus pyogenes serotype T1 in Uppsala county, Sweden 1989-1995.
    Osterlund A
    APMIS; 1996 Mar; 104(3):168-70. PubMed ID: 8611189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resurgence of severe streptococcal diseases: prospects for a streptococcal vaccine.
    Markowitz M
    Int J Tissue React; 1993; 15(3):105-7. PubMed ID: 8188446
    [No Abstract]   [Full Text] [Related]  

  • 31. [Streptococcus antibodies in various population groups with no apparent signs of streptococcal infection. Sero-epidemiological evaluation].
    Angela GC; Brignardello P; Simonetta R; Tosco A
    Arch Sci Med (Torino); 1980; 137(3):525-36. PubMed ID: 7235940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A study of four anti-streptococcal antibodies in rheumatic fever and diseases related with streptococci in childhood].
    Miyazaki H
    Igaku Kenkyu; 1985 Dec; 55(4):200-25. PubMed ID: 3837975
    [No Abstract]   [Full Text] [Related]  

  • 33. Prospects for a group A streptococcal vaccine.
    McMillan DJ; Chhatwal GS
    Curr Opin Mol Ther; 2005 Feb; 7(1):11-6. PubMed ID: 15732524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies.
    Mascini EM; Jansze M; Schellekens JF; Musser JM; Faber JA; Verhoef-Verhage LA; Schouls L; van Leeuwen WJ; Verhoef J; van Dijk H
    J Infect Dis; 2000 Feb; 181(2):631-8. PubMed ID: 10669348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An outbreak of M serotype 1 group A Streptococcus in a neonatal intensive care unit.
    Campbell JR; Arango CA; Garcia-Prats JA; Baker CJ
    J Pediatr; 1996 Sep; 129(3):396-402. PubMed ID: 8804329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis of group A streptococci in mice and efficacy of locally administered streptococcal vaccines.
    Bronze MS; McKinsey DS; Beachey EH; Dale JB
    Trans Assoc Am Physicians; 1988; 101():88-92. PubMed ID: 3077732
    [No Abstract]   [Full Text] [Related]  

  • 37. Purified group a streptococcal M-protein in latex agglutination for detection of type-specific M-antibodies.
    Erwa HH
    Afr J Med Sci; 1973 Oct; 4(4):479-90. PubMed ID: 4792061
    [No Abstract]   [Full Text] [Related]  

  • 38. Kinetic detection of the complement fixing antibodies in the streptococcal infections using the semiautomated complement analyzer IC-81.
    Ungureanu V; Mihalcu F; Mateescu M; Gancevici G
    Arch Roum Pathol Exp Microbiol; 1986; 45(3-4):223-31. PubMed ID: 3606373
    [No Abstract]   [Full Text] [Related]  

  • 39. [Streptozyme test in the diagnosis of streptococcal infections].
    Spina D; Nubile G; Poluzzi G; Lenzi-Guidotti P
    Quad Sclavo Diagn; 1974 Sep; 10(3):370-6. PubMed ID: 4467214
    [No Abstract]   [Full Text] [Related]  

  • 40. Participation of nonspecific factors in destruction of type M 12 streptococci in vitro. IV. Detailed characteristics of nonspecific cofactor and its streptococcal receptor.
    Kahlich R; Procházka O; Dubanská H
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(4):412-25. PubMed ID: 4674091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.